FI54289B - FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF ACTIVE BISPHENOXIC CARBOXYL SYRADERIVAT - Google Patents

FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF ACTIVE BISPHENOXIC CARBOXYL SYRADERIVAT

Info

Publication number
FI54289B
FI54289B FI142572A FI142572A FI54289B FI 54289 B FI54289 B FI 54289B FI 142572 A FI142572 A FI 142572A FI 142572 A FI142572 A FI 142572A FI 54289 B FI54289 B FI 54289B
Authority
FI
Finland
Prior art keywords
syraderivat
bisphenoxic
carboxyl
active
frequency requirement
Prior art date
Application number
FI142572A
Other languages
Finnish (fi)
Other versions
FI54289C (en
Inventor
Yoshio Suzuki
Masayoshi Minai
Noritaka Hamma
Eiichi Murayama
Shunji Aono
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3486771A external-priority patent/JPS5020056B1/ja
Priority claimed from JP3486671A external-priority patent/JPS5030613B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Application granted granted Critical
Publication of FI54289B publication Critical patent/FI54289B/en
Publication of FI54289C publication Critical patent/FI54289C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI142572A 1971-05-22 1972-05-19 FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF ACTIVE BISPHENOXIC CARBOXYL SYRADERIVAT FI54289C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3486771A JPS5020056B1 (en) 1971-05-22 1971-05-22
JP3486671A JPS5030613B1 (en) 1971-05-22 1971-05-22

Publications (2)

Publication Number Publication Date
FI54289B true FI54289B (en) 1978-07-31
FI54289C FI54289C (en) 1978-11-10

Family

ID=26373738

Family Applications (1)

Application Number Title Priority Date Filing Date
FI142572A FI54289C (en) 1971-05-22 1972-05-19 FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF ACTIVE BISPHENOXIC CARBOXYL SYRADERIVAT

Country Status (13)

Country Link
BE (1) BE783702A (en)
CA (1) CA976160A (en)
CH (1) CH577460A5 (en)
DD (1) DD97652A5 (en)
DE (1) DE2224594A1 (en)
DK (1) DK135420B (en)
FI (1) FI54289C (en)
FR (1) FR2138687B1 (en)
GB (1) GB1356747A (en)
HU (1) HU163355B (en)
NL (1) NL148043B (en)
NO (1) NO136249C (en)
SE (1) SE385472B (en)

Also Published As

Publication number Publication date
BE783702A (en) 1972-09-18
SE385472B (en) 1976-07-05
FR2138687A1 (en) 1973-01-05
NL7206316A (en) 1972-11-24
NL148043B (en) 1975-12-15
FR2138687B1 (en) 1975-10-17
FI54289C (en) 1978-11-10
CA976160A (en) 1975-10-14
CH577460A5 (en) 1976-07-15
GB1356747A (en) 1974-06-12
DD97652A5 (en) 1973-05-12
DE2224594A1 (en) 1973-01-18
DK135420B (en) 1977-04-25
NO136249C (en) 1977-08-10
NO136249B (en) 1977-05-02
DE2224594C3 (en) 1975-12-18
DK135420C (en) 1977-10-10
HU163355B (en) 1973-07-28
DE2224594B2 (en) 1975-05-07

Similar Documents

Publication Publication Date Title
FI55997B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION 1 4-DIHYDROKARBOXYLSYRAESTRAR
NO140381C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE ARYLPIPERAZINES
NO137440C (en) ANALOGICAL PROCEDURE FOR PREPARATION OF THERAPEUTICALLY ACTIVE PLEUROMUTILINES
NO137694C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE BENZOMORPHANS
NO142033C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE ISOPROPYLAMINO-3-PHENOXYPROPANOLS
NO138999C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DIPHENYLYL-ALKANOYLAMINOPYRIDINES
NO144153C (en) PROCEDURE FOR PREPARATION OF DELTA3-7-ACYLAMIDO-3-METHYL-CEFEM-4-CARBOXYLIC ACIDS
SE400551B (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-AMINO-5-CARBAMYLBENZOIC ACID DERIVATIVES
NO137858C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE INDANONS
NO143064C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HYDROXYLYCYLXANTINES
NO142077C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N- (1-CYCLOHEXYL-3-PYRROLIDINYL) -BENZAMIDES
FI55988C (en) REFERENCE FOR THERAPEUTIC USE OF THERAPEUTIC THERAPEUTIC O-ACYLPHENOLETHANOLAMINER
FI56834B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF BENZYL SULPHONYL UREA
FI55505C (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF ACTIVE 2-QUINOXALINCARBOXIDE-1 4-DIOXIDE
FI55513B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC DISPENSING OF ALPHA-ACYLOXIALKYLPENICILLINER
FI56670B (en) PROCEDURE FOR FRAMSTATION OF AV 5-CYCLOHEXYL-6-HALOGENINDAN-1-CARBOXYLSYRADERIVAT
NO137727C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 1-PHENYL-3-HYDROXY-3-METHYLTRIAZENES
FI53819C (en) FORMULATION OF NUTRITIONAL THERAPEUTIC NUTRITIONAL N-LYSERGYL-3-AMINOPYRIDINER
FI56371B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC USE OF THERAPEUTIC BENSOYLESTRAR AV 1,8,9-TRIHYDROXIANTRACEN
FI54289B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF ACTIVE BISPHENOXIC CARBOXYL SYRADERIVAT
FI54710B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC THERAPEUTIC ACTIVE 6-AZA-3H-1,4-BENZODIAZEPINER
FI56179C (en) ADJUSTMENT OF THERAPEUTIC FREQUENCY OF THERAPEUTIC
NO137893C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 1-M-TRIFLUOROMETHYLPHENYL-2-CYANOALKYLAMINOPROPANES
SE393616B (en) PROCEDURE FOR MANUFACTURE OF DIHYDROCODEIN
FI56171C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVATED ACYLES PIPERIDINES-